CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. (CTMX) is a publicly traded company in the Unknown sector. Across all available filings, 28 corporate insiders have executed 335 transactions totaling $66.7M, demonstrating a bearish sentiment with -$51.0M in net insider flow. The most recent transaction on Feb 2, 2026 involved a transaction of 980,000 shares valued at $0.
CTMX Insider Activity Summary
Who Is Buying CTMX Stock?
No significant insider buying has been recorded for CTMX in the recent period.
Who Is Selling CTMX Stock?
No significant insider selling has been recorded for CTMX in the recent period.
Is CytomX Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CTMX is bearish with an Insider Alignment Score of 12/100 and a net flow of -$51.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CTMX Frequently Asked Questions
Understanding CTMX Insider Activity
Insider trading at CytomX Therapeutics, Inc. (CTMX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 28 insiders are actively trading CTMX stock, having executed 335 transactions in the past 90 days. The most active insider is Gp, Llc Trv (Executive), who has made 4 transactions totaling $28.7M.
Related Tools
Track CytomX Therapeutics, Inc. Insider Activity
Get notified when executives and directors at CTMX file new Form 4 transactions